Jun 10, 2010 (Close-Up Media via COMTEX) --

Geron Corp. has announced the presentation of data from the clinical trial of imetelstat (GRN163L), the company's telomerase inhibitor drug, in combination with paclitaxel and bevacizumab in patients with breast cancer at the 2010 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

In a release, the Company noted:

An interim analysis of the Phase 1 trial was presented by Geron clinical scientists and collaborating principal investigators from Ingalls Memorial Hospital, Harvey, IL and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN.

Read More

Update: Late in the afternoon of April 15, the U.S. Senate voted 58-34 for a bill that freezes Medicare payment rates at the previous 2010 level until June 1. The House of Representatives was scheduled to take up the bill later that evening and send it to President Obama for his signature. The April 14 deadline came and went with no action from the U.S. Congress, so the 21.3-percent cut in physicians' Medicare payments officially took effect today (April 15).

Read More

To view Oncology Learning Center's calendar of Oncology industry events, click the following link:  http://www.oncologylearningcenter.com/calendar.php

To view the October 09 SWON Newsletter, click here.

To view the August 09 SWON Newsletter, click here.

To view the July 09 SWON Newsletter, click here.

To view the June 09 Newsletter, click here